Clinical Trials Directory

Trials / Completed

CompletedNCT01712360

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of NAFT-500 in Pediatric Subjects With Tinea Cruris and Tinea Pedis and NAFT-600 in Pediatric Subjects With Tinea Pedis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Merz North America, Inc. · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is being done to see how the body is affected when a study drug is applied to both feet if the subject has athlete's foot or to both feet and the groin area if the subject has both athlete's foot and jock itch. Safety of the drug and how well the drug works will also be measured.

Detailed description

Study population, diagnosis, and main criteria for inclusion: Tinea pedis and Tinea cruris (NAFT-500): Male or non-pregnant female subjects aged 12 to 17 years, 11 months old of any race with Tinea pedis and Tinea cruris infections confirmed by a positive potassium hydroxide (KOH) analysis from both the feet and bikini area. Both cases (feet and bikini area) must be characterized by clinical evidence of a Tinea pedis and Tinea cruris infection. Additional, approximately 4 pharmacokinetic (PK) evaluable adult subjects with the same condition will serve as a control. Tinea pedis (NAFT-600): Male or non-pregnant female subjects aged 12 to 17 years, 11 months old of any race with Tinea pedis infection confirmed by a positive potassium hydroxide (KOH) analysis from both feet. Both feet must be characterized by clinical evidence of a Tinea pedis infection. Additional, approximately 4 pharmacokinetic (PK) evaluable adult subjects with the same condition will serve as a control.

Conditions

Interventions

TypeNameDescription
DRUGNAFT500 (pediatric)Applied to both feet and groin area
DRUGNAFT600 (pediatric)Applied to both feet only
DRUGNAFT500 (adult)Applied to both feet and groin area
DRUGNAFT600 (adult)Applied to both feet

Timeline

Start date
2012-10-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2012-10-23
Last updated
2016-07-14
Results posted
2016-07-14

Locations

4 sites across 3 countries: United States, Dominican Republic, Honduras

Source: ClinicalTrials.gov record NCT01712360. Inclusion in this directory is not an endorsement.